Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development.

Diagnostic strategy of diabetic polyneuropathy has progressed. In particular, Baba's classification on the severity of diabetic polyneuropathy using nerve conduction study and a point-of-care device of nerve conduction study will realize the objective quantitative evaluation of diabetic polyneuropathy.